期刊文献+

良性前列腺增生临床调研报告 被引量:15

Clinical questionnaires about benign prostatic hyperplasia
原文传递
导出
摘要 目的了解我国泌尿外科医师对良性前列腺增生(BPH)的认识程度以及BPH患者的临床特点。方法调研对象为全国119家三级甲等医院的部分专职泌尿外科医师和BPH患者。医师问卷主要包括泌尿外科医师对BPH临床进展性的认识以及目前的诊治措施等问题。患者问卷主要包括BPH发病年龄、症状特点以及接受治疗的愿望等问题。结果对合格的289份医师问卷和4253份患者问卷的分析结果显示98.6%的泌尿外科医师认为BPH是一种临床进展性疾病,但是对临床进展性高危因素的认识还存在一定的分歧。同时,98.1%的患者就诊时属于中、重度BPH,夜尿是影响患者生活质量的最主要症状。治疗过程中泌尿外科医师以及BPH患者共同关心的问题就是迅速改善下尿路症状。结论本调研是第一次针对泌尿外科医师和BPH患者的专项临床调研,调研结果将从一个侧面反映我国BPH的治疗现状并有利于我国BPH诊疗指南的不断完善。 Objectives To assess the understanding degree of urologists for benign prostatic hyperplasia (BPH) and the clinical characteristics of BPH patients. Methods The questionnaires was distributed to urologists and patients in 119 hospitals over the country, respectively. The urologist survey was mainly focused on the questions of BPH progression and therapeutic model. The patient survey was mainly focused on the questions of patient's age, symptom features and the preference to receiving treatment. Results The evaluations based on 289 completed urologist questionnaires and 4253 completed patient questionnaires showed that 98.6% of urologists agreed that BPH was a progressive disease but there were still some differences in understanding the risk factors for BPH progression. Additionally, 98. 1% of patients were diagnosed to be moderate or severe BPH, nocturia was the most frequent symptom. In the treatment for BPH, both the urologists and patients concerned about how to improve the system rapidly. Conclusions This study is the first questionnaires specifically to the urologists and BPH patients, the results would reflect the situations of BPH diagnosis and treatment in China and would be helpful to the development of BPH guideline.
出处 《中华外科杂志》 CAS CSCD 北大核心 2008年第15期1153-1155,共3页 Chinese Journal of Surgery
关键词 前列腺增生 问卷调查 医师 患者 Prostatic hyperplasia Questionnaires Physicians Patients
  • 相关文献

参考文献8

  • 1张祥华,王行环,王刚,等.良性前列腺增生诊断治疗指南//那彦群.中国泌尿外科疾病诊断治疗指南.2007版.北京:人民卫生出版社,2007:167-204.
  • 2Madersbacher S, Alivizatos G, Nordling J, et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol, 2004, 46:547-554.
  • 3McConnell JD, Roehrbom CG, Baustita OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 2003, 349:2387-2398.
  • 4Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol, 1999, 162:1301-1306.
  • 5Roehrbohn CG, McConnell JD, Bonilla J, et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia: PLESS study. J Urol, 2000, 163:13-20.
  • 6Hutchison A, Farmer R, Verhamme K, et al. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Eur Urol,2007, 51:207-215.
  • 7Djavan B, Nickel JC, de la Rosette J, et al. The urologist view of BPH progression:results of an international questionnaires. Eur Urol, 2002, 41:490-496.
  • 8Roehrborn CG, McConnell JD. Etiology, pathothysiology, epidemiology and natural history of binign prostatic hyperplasia// Walsh PC, Retik AB, Vaughan ED, et al. Campbell' s Urology. Philadelphia : WB Saunders Company, 2002 : 1297-1330.

共引文献22

同被引文献158

引证文献15

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部